Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2020 3
2021 3
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Developing a paediatric drug formulary for the Netherlands.
van der Zanden TM, de Wildt SN, Liem Y, Offringa M, de Hoog M; Dutch Paediatric Pharmacotherapy Expertise Network NKFK (Nederlands Kenniscentrum voor Farmacotherapie bij Kinderen). van der Zanden TM, et al. Arch Dis Child. 2017 Apr;102(4):357-361. doi: 10.1136/archdischild-2016-311674. Epub 2016 Oct 31. Arch Dis Child. 2017. PMID: 27799154 Review.
Neonatal Drug Formularies-A Global Scope.
Shaniv D, Bolisetty S, Young TE, Mangum B, Ainsworth S, Elbers L, Schultz P, Cucchi M, de Wildt SN, van der Zanden TM, Caldwell N, Smits A, Allegaert K. Shaniv D, et al. Among authors: van der zanden tm. Children (Basel). 2023 May 8;10(5):848. doi: 10.3390/children10050848. Children (Basel). 2023. PMID: 37238396 Free PMC article.
Off-Label, but on-Evidence? A Review of the Level of Evidence for Pediatric Pharmacotherapy.
van der Zanden TM, Smeets NJL, de Hoop-Sommen M, Schwerzel MFT, Huang HJ, Barten LJC, van der Heijden JEM, Freriksen JJM, Horstink AAL, Holsappel IHG, Mooij MG, de Hoog M, de Wildt SN. van der Zanden TM, et al. Clin Pharmacol Ther. 2022 Dec;112(6):1243-1253. doi: 10.1002/cpt.2736. Epub 2022 Sep 25. Clin Pharmacol Ther. 2022. PMID: 36069288 Free PMC article. Review.
Benefit-Risk Assessment of Off-Label Drug Use in Children: The Bravo Framework.
van der Zanden TM, Mooij MG, Vet NJ, Neubert A, Rascher W, Lagler FB, Male C, Grytli H, Halvorsen T, de Hoog M, de Wildt SN. van der Zanden TM, et al. Clin Pharmacol Ther. 2021 Oct;110(4):952-965. doi: 10.1002/cpt.2336. Epub 2021 Jul 29. Clin Pharmacol Ther. 2021. PMID: 34145575 Free PMC article.
Best Evidence-Based Dosing Recommendations for Dexmedetomidine for Premedication and Procedural Sedation in Pediatrics: Outcome of a Risk-Benefit Analysis By the Dutch Pediatric Formulary.
Freriksen JJM, van der Zanden TM, Holsappel IGA, Molenbuur B, de Wildt SN. Freriksen JJM, et al. Among authors: van der zanden tm. Paediatr Drugs. 2022 May;24(3):247-257. doi: 10.1007/s40272-022-00498-y. Epub 2022 Mar 28. Paediatr Drugs. 2022. PMID: 35344192 Free PMC article.
12 results